| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.1M | +203.9% |
| SG&A Expense | $7.9M | -37.1% |
| Operating Income | -$16.0M | -7.8% |
| Pre-tax Income | -$15.5M | -11.3% |
| Net Income | -$16.0M | -14.5% |
| EPS (Basic) | -$0.42 | +23.6% |
| EPS (Diluted) | -$0.42 | +20.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | -50.7% |
| Current Assets | $16.7M | -51.0% |
| Total Assets | $26.1M | -42.2% |
| Current Liabilities | $2.6M | +40.3% |
| Total Liabilities | $2.7M | +1.4% |
| Stockholders' Equity | $23.4M | -44.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $34K | -90.9% |